• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Wyeth

Wyeth

Pfizer Inc PFE 3 Star

Last Price$29.38Day Change (%)-0.37%
Open Price$29.43Day Change ($)-0.11
Day Range29.36–29.6752-Week Range27.81–32.96

As of Thu 08/28/2014 07:11 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  5. Research
  1. Investor or Speculator?

    Progenics Pharmaceuticals PGNX and partner Wyeth WYE announced Thursday that both the Food and Drug Administration and the European Medicines Agency have accepted new drug applications for subcutaneous MNTX, which aims to treat postoperative ileus and opioid bowel dysfunction. We are leaving our ...

  2. A Shift in Health-Care M&A Activity

    Recent deals have been driven more by tax strategies than therapeutic synergies.

  3. Mallinckrodt Announces Key Leadership Appointments Following Completion of Questcor Acquisition

    Mallinckrodt Announces Key Leadership Appointments Following Completion of Questcor Acquisition

  4. Grant & Eisenhofer Represents Whistleblowers in Nearly $100 Million Settlement With Community Health Systems, Resolving Claims that Medicare/Medicaid Payors Were Bilked by Excessive ER Admissions

    Grant & Eisenhofer Represents Whistleblowers in Nearly $100 Million Settlement With Community Health Systems, Resolving Claims that Medicare/Medicaid Payors Were Bilked by Excessive ER Admissions

  5. What Two Great Managers Are Buying

    Inside Clipper Fund's makeover.

  6. Finding Moats in Big Pharma's Consumer Health Units

    We believe breakups could unlock value for big pharma shareholders.

  7. Invest in Johnson & Johnson and Still Enjoy Diversification

    ETFs provide a great means to gain exposure to this battered health-care giant.

  8. Health-Care Investing Alive and Well

    Two veteran investors discuss the winners and losers of reform and where they're looking for future growth.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.